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Mosquito-borne viruses are known to cause disease in humans and livestock and are often
difficult to control due to the lack of specific antivirals and vaccines. The Wolbachia
endosymbiont has been widely studied for its ability to restrict positive-strand RNA virus infection
in mosquitoes, although little is known about the precise antiviral mechanism. In recent years, a
variety of insect-specific viruses have been discovered in mosquitoes and an interaction with
mosquito-borne viruses has been reported for some of them; however, nothing is known about
the effect of Wolbachia on insect-specific virus infection in mosquitoes. Here, we show that
transinfection of the Drosophila-derived wMelPop Wolbachia strain into Aedes aegypti-derived
cells resulted in inhibition and even clearance of the persistent cell-fusing agent flavivirus
infection in these cells. This broadens the antiviral activity of Wolbachia from acute infections to
persistent infections and from arboviruses to mosquito-specific viruses. In contrast, no effect on
the Phasi Charoen-like bunyavirus persistent infection in these cells was observed, suggesting a
difference in Wolbachia inhibition between positive- and negative-strand RNA viruses.
INTRODUCTION
Arboviruses are comprised of human and animal pathogens
that are transmitted via blood-feeding arthropod vectors,
including mosquitoes. Due to the lack of efficient antivirals
and vaccines against most of these viruses, vector control is
an important intervention strategy to reduce the impact of
these viruses on human and animal health (Kean et al.,
2015; Weaver & Reisen, 2010). In recent years, the use of
the endosymbiotic intracellular bacterium, Wolbachia, has
been a well-studied approach to control arbovirus transmis-
sion by mosquitoes and in particular by Aedes aegypti
(Iturbe-Ormaetxe et al., 2011; Rainey et al., 2014). Wolba-
chia was first shown to confer resistance to RNA viruses in
Drosophila-virus systems (Hedges et al., 2008; Teixeira
et al., 2008). Later, transinfection of Drosophila-derived
Wolbachia into A. aegypti (which is not known to naturally
harbour these endosymbionts) or its derived cell lines
resulted in resistance to the important mosquito-borne
dengue (DENV) and chikungunya viruses (Moreira et al.,
2009; Walker et al., 2011). This has resulted in successful
field trials of A. aegypti transinfected with Wolbachia, prov-
ing its ability to reduce DENV transmission in natural
settings (Frentiu et al., 2014). Moreover, Wolbachia can be
stably maintained in nature, as crosses between non-
infected females and infected males do not result in any off-
spring (Hoffmann et al., 2011, 2014). This unique feature is
called cytoplasmic incapability (McMeniman et al., 2009)
and gives a reproductive advantage to infected female mos-
quitoes, resulting in the spread of Wolbachia through the
mosquito population (Sinkins, 2004).
The mechanism(s) of virus inhibition through Wolbachia is
not known. Inhibition has been linked to Wolbachia den-
sity, with the resistant phenotype observed only with Wol-
bachia strains producing high concentrations of bacteria in
infected cells (Osborne et al., 2009, 2012). Recent findings
show the ability of Wolbachia to interfere with early events
in virus replication, suggesting an intrinsic mechanism for
viral resistance (Rainey et al., 2016).
It should be noted that Wolbachia-mediated virus resistance
has only been reported for positive-stranded RNA viruses
and no resistance has yet been reported for negative-
stranded RNA viruses (Rainey et al., 2014), which include a
variety of important mosquito-borne viruses such as Rift
Valley fever virus (Bunyaviridae).
Further to arboviruses, mosquitoes have also been shown to
be infected with additional viruses, called insect-specific
viruses (ISVs) as they replicate exclusively in insect cells.
The list of ISVs is steadily increasing through novel identifi-
cation methods, including next-generation sequencing.
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ISVs belong to different virus families/genera, including the
Bunyaviridae and Flaviviridae families, which also include
important arboviruses. ISVs belonging to the Flavivirus
genus share sequence similarities with their arbovirus coun-
terparts, but cluster as a single defined group suggesting
independent evolution. In contrast, ISVs belonging to the
Bunyaviridae cluster into several defined groups across the
virus family (Bolling et al., 2015; Marklewitz et al., 2015).
ISV infections, at least in cell culture, normally result in ini-
tial cytopathic effect, followed by progression into a persis-
tent, non-cytopathic infection (Bolling et al., 2015;
Marklewitz et al., 2015).
The increasing numbers of ISVs identified in mosquitoes
and derived cells suggest that a large number of mosquitoes
in the wild are naturally infected with ISVs and that vertical
transmission is the main infection and maintenance route.
Thereby one can expect that mosquitoes in the wild can be
infected by several viruses, including ISVs and/or
arboviruses. Moreover, the interaction between ISV and
arbovirus infections (either co-infected or sequentially
infected) results in either inhibition or increased replica-
tion/infection of one of the viruses (Kean et al., 2015). It is
suggested that such interactions could partly define vector
competence of a mosquito in the wild to a given arbovirus.
No information is available at the moment about the inter-
action of Wolbachia with these ISVs or what effect Wolba-
chia transinfection could have on mosquitoes already
persistently infected with RNA viruses. The inhibitory effect
of Wolbachia on RNA viruses has only been investigated in
light of an acute virus infection following a persistent Wol-
bachia transinfection (Rainey et al., 2014).
In order to address these questions and to understand if
Wolbachia interacts with acute or persistent infections of
ISVs, we have used the A. aegypti-derived Aag2 cell line
previously transinfected with the Drosophila-derived Wol-
bachia strain wMelPop (known to grow to high titres and
mediate DENV resistance) (Hedges et al., 2008; Teixeira
et al., 2008) to investigate the effect of Wolbachia on two
ISVs, known to be present in Aag2 cells and belonging to
different families: positive-strand RNA cell-fusing agent
virus (CFAV, Flaviviridae) (Scott et al., 2010) and the nega-
tive-strand RNA Phasi Charoen-like bunyavirus (PCLV,
Bunyaviridae) (Maringer et al., 2015). Our results show
that Wolbachia can refer resistance to CFAV infection inde-
pendently of the time of Wolbachia transinfection. In con-
trast, no viral inhibition by Wolbachia was observed for
PCLV in these experiments.
RESULTS
Effect of Wolbachia on small RNA production in
Aag2 cells
Aag2 cells can be stably transinduced with the wMelP strain
of Drosophila, resulting in a reduction of small RNAs in the
cytoplasm due to inhibition of small RNA transport from
the nucleus to the cytoplasm (Mayoral et al., 2014). Aag2
cells are known to be persistently infected with the insect-
specific flavivirus, CFAV and as result produce CFAV-spe-
cific small RNAs (Scott et al., 2010). Recently it has also been
reported that Aag2 cells produce transcripts and proteins
from another ISV, PCLV (suggesting a persistent infection)
(Maringer et al., 2015). However, it is not yet known if this is
due to an active virus infection. This virus has also been
recently discovered in wild mosquitoes in Brazil (Aguiar
et al., 2015). Therefore, we re-analysed the previously
reported small RNA data of Aag2 and Aag2wMelPop cells
(Mayoral et al., 2014) and mapped them to CFAV or PCLV.
Almost no small RNA reads were detected in Aag2wMelPop
cells mapping to CFAV, despite being observed in the paren-
tal Aag2 cells (Fig. 1a). The majority of CFAV small RNAs in
the parental Aag2 cells were 21 nt in size, with similar
amounts mapping to the genome and the antigenome. In
contrast, small RNAs mapping against PCLV were identified
in Aag2 cells and Aag2wMelPop cells, with a higher percent-
age in the Aag2wMelPop cells (Fig. 1b). The majority of
PCLV small RNAs were 26–30 nt, mapped to the anti-
genome and had sequence specificities seen for ping-pong-
derived PIWI-interacting RNAs (piRNAs) (adenine at
positionp 10, A10, and uridine at position 1, U1) (Fig. S1,
available in the online Supplementary Material). The S-seg-
ment could be considered as the highest producer of PCLV-
specific small RNAs, followed by the L- and M-segments.
For the S- and M-segments, a bias could be observed for
small RNAs of 26–30 nt mapping mainly to the anti-genome.
For the L-segment, similar amounts of small RNAs mapping
to the genome/anti-genome were detected with a slight bias
for the genome (Fig. 1c). Small RNAs of 26–30 nt mapping
to the genome and antigenome of CFAV were detected only
in parental Aag2 cells and were absent from Aag2wMelPop
cells (Fig. 1a). These 26–30 nt RNAs contained the U1 bias,
but lacked the A10 bias (Fig. S2). The small number of
CFAV-specific small RNAs 26–30 nt in length meant it was
not possible to analyse the sequence logos for the CFAV-spe-
cific sequences in Aag2wMelPop cells. The presence or
absence of wMelPop, as well as PCLV and CFAV in these
cells, was determined by reverse transcription PCR (RT-
PCR) (Fig. 1d). These data suggested that wMelPop reduces
or even clears CFAV infection in persistently infected Aag2
cells, but has no or little effect on PCLV.
Effect of Wolbachia on persistent or acute ISV
infection in Aag2 cells
The presence of active PCLV production/infection in Aag2
and Aag2wMelPop cells was further confirmed by RT-PCR
and was also detected following the transfer of supernatant
from these cells to C6/36 cells, resulting in PCLV-positive
C6/36 cells (Fig. 2a, b). CFAV was easily detected by RT-
PCR in Aag2 cells, as well as in C6/36 cells incubated with
Aag2 supernatant, in contrast to Aag2wMelPop or C6/36
cells incubated with Aag2wMelPop supernatant (Fig. 2a, b).
To determine if the presence of wMelPop in Aag2 cells
cured the cells from CFAV infection or just strongly
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inhibited CFAV replication/infection, Aag2wMelPop cells
were treated with tetracycline over several passages, result-
ing in the loss of Wolbachia. The absence of Wolbachia in
Aag2wMelPop-tetracyline-treated cells (called Aag2wMel-
Pop-tet) was confirmed by RT-PCR (Fig. 2a). Similar to
what is seen in the parental Aag2wMelPop cells, no CFAV
could be detected in Aag2wMelPop-tet cells (Fig. 2a), even
when a different region of the CFAV genome was used for
detection (Fig. S3a) or in C6/36 cells incubated with Aag2w-
MelPop-tet supernatant (Fig. 2b). In contrast, PCLV was
detected in each of these samples (Fig. 2a, b). This suggested
that wMelPop transinfection cures Aag2 cells of persistent
CFAV infection, but has no effect on PCLV. To exclude the
possibility that tetracycline treatment per se inhibits CFAV,
Aag2 cells were treated with tetracycline and CFAV levels
were monitored over time. No effect on CFAV could be
detected in tetracycline-treated Aag2 cells compared to
untreated cells (Fig. S3b).
To determine whether wMelPop has a similar effect on
acute ISV infection, Aag2wMelPop and Aag2wMelPop-tet
cells were incubated with Aag2 supernatant containing both
CFAV and PCLV, and viral RNA detected by quantitative
RT-PCR (Fig. 2c, d, respectively). Significantly less CFAV
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Fig. 1. Presence or absence of CFAV, PCLV and wMelPop in Aag2 and Aag2wMelPop cells. Size distribution of small RNA
molecules mapping to the CFAV (a) or PCLV (b) genome (black)/anti-genome (grey) in A. aegypti-derived Aag2 or wMelPop-
transinfected Aag2 cells. (c) Size distribution of small RNA molecules mapping to the different segments of PCLV (S, M and L)
genome/anti-genome in A. aegypti-derived Aag2 or wMelPop-transinfected Aag2 cells. (d) Detection of CFAV or PCLV in
Aag2 and Aag2wMelPop cells by RT-PCR. Actin was used as loading control.
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RNA was detected in Aag2wMelPop compared to Aag2w-
MelPop-tet cells. In contrast, no significant difference in
PCLV RNA was observed under any of the test conditions.
In summary, these results show that wMelPop can inhibit
CFAV infection in Aag2 cells, regardless of whether it is an
acute or persistent infection, even resulting in total loss of
CFAV in case of persistently infected cells. In contrast, no
effect of PCLV was observed by wMelPop in Aag2 cells.
DISCUSSION
Wolbachia endosymbionts have been studied for their abil-
ity to restrict RNA virus infection in Drosophila and A.
aegypti mosquitoes, as well as their derived cell lines (Kean
et al., 2015; Rainey et al., 2014). Little is known about the
effects mediated by Wolbachia to induce antiviral activity,
although density has been reported to be important
(Osborne et al., 2009, 2012). Moreover, Wolbachia has
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Fig. 2. Effect of wMelPop on CFAV and PCLV infection in Aag2 cells. (a) Detection of CFAV, Wolbachia or PCLV in Aag2,
Aag2wMelPop and two different cultures of Aag2wMelPop cells treated with tetracycline (Aag2wMelPop-tet sets 1 and 2)
cells by RT-PCR. Actin was used as loading control. (b) Detection of CFAV or PCLV in C6/36 cells incubated with superna-
tant of Aag2, Aag2wMelPop or Aag2wMelPop treated with tetracycline (two different cultures, Aag2wMelPop-tet sets 1 and
2) by RT-PCR. Actin was used as a loading control. (c) Quantification of CFAV RNA in Aag2wMelPop (Wol) or Aag2wMelPop
treated with tetracycline (Tet) cells after incubation with Aag2 supernatant containing CFAV by SYBR Green. S7 was used as
internal control. Relative RNA expression is represented as (CFAV/S7). Error bars show SEM from three independent experi-
ments. (d) Quantification of PCLV RNA in Aag2wMelPop (Wol) or Aag2wMelPop treated with tetracycline (Tet) cells, either
after incubation with Aag2 supernatant harbouring PCLV or untreated by SYBR Green. S7 was used as an internal control.
Relative RNA expression is represented as (PCLV/S7) and mock-infected tetracycline cells were set to 1. Error bars show SEM
from three independent experiments. *P0.05.
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recently been shown to inhibit early events during viral
infection (Rainey et al., 2016). Over the last decade, a vari-
ety of ISVs have been discovered in mosquitoes and for
some of them an interaction with mosquito-borne viruses
has been reported that may be either beneficial or disadvan-
tageous for these viruses (Bolling et al., 2015; Kean et al.,
2015). However, nothing is known about the effect of Wol-
bachia transinfection on ISVs present in mosquitoes and
whether there is a difference in the interaction depending
on the virus (e.g. positive- versus negative-strand RNA
virus). Transinfection of wMelPop into A. aegypti-derived
Aag2 cells resulted in the inhibition and even clearance of
persistent CFAV infection in these cells, broadening the
antiviral activity of Wolbachia from acute infection to per-
sistent infection. This could also be observed at the level of
small RNA production, which was produced in Aag2 cells
but not wMelPop Aag2 cells. Similar antiviral effects by
Wolbachia were observed when these cured cells were
freshly infected with acute CFAV infection. In contrast, no
effect on PCLV persistent infection in these cells was
observed after wMelPop transinfection; in addition, super-
infection of PCLV in previously transinfected wMelPop
cells resulted in no difference in PCLV replication. As
expected from these results, small RNAs against PCLV were
produced in both Aag2 and wMelPop Aag2 cells.
CFAV-specific small RNAs showed a bias for 21 nt, the typi-
cal size of Dicer-2-produced small interfering RNAs, as pre-
viously reported for CFAV (Scott et al., 2010) and other
arthropod-borne flaviviruses (West Nile virus and DENV).
In contrast, PCLV-specific small RNAs were mainly 26–
30 nt in size, had a bias for the anti-genome and showed
sequence-specific features for ping-pong-derived piRNAs
(A10 and U1 bias) (Fig. S1). Similar results have been
reported for other arthropod-borne bunyaviruses (Leger
et al., 2013; Schnettler et al., 2013b), specifically for Rift
Valley fever virus infection at later time points of infection
(Leger et al., 2013). Interestingly, CFAV small RNAs of
length 26–30 nt show the classic ping-pong signature of U1
bias in the positive (genome) orientation, but lack the A10
bias in the negative (anti-genome) orientation (Fig. S2).
This raises the question whether these small RNAs are in
fact piRNAs, whether just one type of piRNAs is produced
in CFAV infection of Aag2 cells or whether some small
RNAs are products of some other RNA decay pathway.
These results illustrated a difference in the ability of the
endosymbiont to interfere with persistently infecting ISVs
from different families. Until now Wolbachia has only been
reported to have an antiviral effect against positive-strand
RNA viruses during an acute infection (Frentiu et al., 2014;
Martinez et al., 2014; Rainey et al., 2014, 2016), and the lack
of effect of Wolbachia on PCLV is the first study to look at
the interaction with a negative-strand RNA virus. Whether
the observed lack of antiviral activity by Wolbachia is PCLV
specific, or could be broadened to other negative-strand
RNA viruses, still requires investigation. No antiviral effect
was observed when persistently PCLV-infected and wMel-
Pop-positive cells were superinfected with PCLV. It is not
yet known whether this is due to the inability of wMelPop
to inhibit PCLV infection, even at an acute stage of infec-
tion, or due to the inability of Aag2 cells to be superinfected
with PCLV. Nonetheless, this raises some important ques-
tions for the field. For example, is Wolbachia-mediated
inhibition limited to certain virus families and, if so, why is
this the case? Could this be linked with the different small
RNA profiles observed for flaviviruses versus bunyaviruses?
How does this drive evolution of arboviruses or ISVs fol-
lowing the artificial introduction of Wolbachia into vector
mosquitoes? What are the interactions between Wolbachia
and ISVs and how do they influence vector competence in
ISV-infected mosquitoes? Moreover, could it, for example
during larger outbreaks involving many arboviruses, chan-
nel certain types of mosquito-borne pathogens and result in
preferential amplification? Co-infection studies in mosquito
systems with different families of arboviruses as well as ISVs
are required to answer such questions.
In summary, wMelPop was able to efficiently inhibit per-
sistent and acute infection of the positive-strand RNA
insect-specific CFAV in Aag2 cells, but had no effect on
persistent infection by the negative-strand RNA PCLV.
Future research will have to investigate the effect of Wolba-
chia transinfection on other ISVs, as well as its effect on
the complex interplay among ISVs, arboviruses and the
mosquito vector, and how this influences/changes vector
competence to different mosquito-borne viruses.
METHODS
Cells and viruses. A. aegypti-derived Aag2 wt, wMelPop-transinfected
or wMelPop-transinfected and treated with tetracycline were maintained
in Mitsuhashi and Maramorosch/Schneider’s (50 : 50) media supple-
mented with 10% FCS and 10% tryptose phosphate broth and Pen-
Strep at 26

C. Aag2- and wMelPop-transinfected cells were received
from S. O’Neill and have been described previously (Mayoral et al.,
2014). Aag2wMelPop-tet cells were produced by passaging Aag2wMel-
Pop cells with 10µgml 1 tetracycline for four passages and maintained
as described. C6/36 cells were maintained in L15 medium supplemented
with 10% FCS and 10% tryptose phosphate broth and PenStrep at
28

C. CFAV and PCLV were derived from Aag2 wt supernatant.
Reverse transcription, PCR and quantitative RT-PCR. RT-PCR
was performed with total RNA (1500 ng) isolated using TRIzol (Invitro-
gen), Superscript III and oligo-dT primer, according to the manufac-
turer’s protocol. CFAV, PCLV, Wolbachia and actin were detected and
amplified by PCR (2µl of the cDNA reaction) using corresponding pri-
mers [PCLV-N-FW: CAGTTAAAGCATTTAATCGTATGATAA,
PCLV-N-RV: CACTAAGTGTTACAGCCCTTGGT, CFAV (3359 nt)-
FW: GTTGACGACATATTGAAGAGATACG, CFAV (4060)-RV:
GCCAAGGATACAGTCCAAAAC, CFAV-3UTR-FW: TAGACGTGA
TCGAATAGAGCCG, CFAV-3UTR-RV: GCGCATCTATGGTA
TAGAAAAGATAAT or as described previously (Rainey et al., 2016;
Schnettler et al., 2013a)]. Quantitative detection of CFAV, PCLV and
the housekeeping gene S7 was performed using specific primers [PCLV-
N-qRT-FW: ATAGTGTGGGACGAGGAGGG, PCLV-N-qRT-RV:
AGGTGCCAACAGGAAACACT, CFAV-qRT-FW: CTGATGTGCG
TGCAGTTCTT, CFAV-qRT-RV: CACAACGGTAGCGAGAGACA or
as described previously (McFarlane et al., 2014)], SYBR Green Master
Mix (Applied Biosystems) and an ABI7500 Fast cycler according to
manufacturer’s protocol.
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Virus infection. Aag2wMelPop or Aag2wMelPop-tet cells were incu-
bated with 200 µl Aag2 supernatant for 24h, followed by 3 PBS washes
and addition of fresh culture medium. RNA was isolated at 48h post-
infection.
Small RNA analysis. Small RNA reads from Aag2 (SRR1174240 and
SRR1174241) and Aag2wMelPop cells (SRR1174242 and SRR1174243)
published previously (Mayoral et al., 2014) were re-analysed. The data-
sets were downloaded from the SRA database and FastqQ reads were
extracted using SRA toolkit. Using blastn, these reads were mapped to
the CFAV (NCBI accession number NC_001564.1) and PCLV (NCBI
accession numbers KR003786.1, KR003784.1 and KR003785.1 corre-
spond to L, M and S segments, respectively) genome and anti-genome.
Hits that matched and 20–30nt with one maximum mismatch were
taken for later analysis. These hits were further categorized into two
groups, mapping to both the genome and the anti-genome.
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